Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks slammed by lockdown fears, end six-week rally

Fri, 19th Nov 2021 10:34

* Austria reimposes full lockdown

* Lagarde reaffirms dovish stance

* Hermes soars again index inclusion talk
(Adds comments, updates prices throughout)

By Anisha Sircar and Shreyashi Sanyal

Nov 19 (Reuters) - European stocks ended in the red on
Friday, clocking their first weekly decline in seven weeks on
concerns over the economic damage from fresh COVID-19 lockdowns
in the region that hammered cyclical sectors such as banks and
automakers.

The pan-European STOXX 600 index fell 0.3% after
hovering near record highs earlier in the session. The index
ended the week 0.1% lower.

It lost ground after news that Austria will become the first
country in western Europe to reimpose a full COVID-19 lockdown
this autumn to tackle a new wave of infections.

Germany's Health Minister Jens Spahn said the coronavirus
situation in the country was so grave that a lockdown, including
for people who have been vaccinated, cannot be ruled out.

"Any thoughts that the vaccines would offer a way to a more
normal Christmas period appear to have gone up in smoke for now,
in Europe at least, although there is a nagging fear this could
ripple out across the region," said Michael Hewson, chief market
analyst at CMC Markets.

Frankfurt shares fell 0.4%, while sectors more
exposed to economic cycles such as banks, automakers
and travel & leisure fell between 1.5% and 2.2%.

South European markets, including those in Spain and
Italy, fell about 1.5% each.

European stocks have hit a series of record highs this month
as a stronger-than-expected earnings season helped investors
look past concerns about rising inflationary pressures.

European Central Bank President Christine Lagarde said
inflation in the euro zone will fade so the ECB should not
tighten policy as it could choke off the recovery, and hinted at
continued bond purchases next year.

The ECB is due to decide on the future of its bond-purchase
programmes at its Dec. 16 policy meeting.

Irish airline Ryanair dropped 2.3% after announcing
its intention to delist from the London Stock Exchange,
citing costs related to retaining an additional listing.

French luxury group Hermes gained 5.2%, after
jumping more than 6% in the previous session, on market talks
that it may be added to the Eurostoxx 50 index during a December
review.
(Reporting by Anisha Sircar, Shreyashi Sanyal and Sruthi
Shankar in Bengaluru; Editing by Shounak Dasgupta,Aditya Soni
and Marguerita Choy)

More News
12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

Read more
10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of non-small cell lung cancer.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the European Union.

Read more
3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.

Read more
2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low levels of the mutant protein targeted by the drug, according to trial results announced on Sunday.

Read more
2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by about five months for people with low levels of HER2 protein whose cancer progressed following endocrine therapy, according to research presented on Sunday.

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.